About Hemmo Pharmaceuticals Private Limited
Data last updated:
Hemmo Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Hemmo Pharma Llp. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 November 1979.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U17100MH1979PTC021857. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹29.08 Lakh. It was formerly known as Jashan Textile Mills Private Limited. It was led by directors including Surinder Bhawanidas Gulati and Madhu Vikram Utamsingh.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at 114 Turf Estate 3/65 Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011.
As per the financials filed for FY 2021, the company reported a revenue of ₹133.32 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹42.7 Cr (net margin 32%) and EBITDA of ₹61.64 Cr (EBITDA margin 46.2%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 24% over five years.
The company had about 325 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Hemmo Pharmaceuticals. As per MCA filings, the company had open charges of ₹25 Cr and satisfied charges of ₹1.06 Cr on record. Court records list 19 cases involving the company, including 13 filed by the company and 6 filed against it; 1 case is pending. The company has 1 deal on record (1 acquisition); the latest was in March 2021. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Alpa Laboratories Limited with revenue of ₹135.8 Cr.
The last known website on record is hemmopharma.com.
Company details
Contact details
Hemmo Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is hemmopharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address114 Turf Estate 3/65 Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hemmo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Hemmo Pharmaceuticals operates one associated brand: Hemmo Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Synthetic peptides are manufactured for research, clinical, and commercial applications. | hemmopharma.com |
Business activity
The main business activity of Hemmo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hemmo Pharmaceuticals Private Limited, buy the company report.
Financials of Hemmo Pharmaceuticals Private Limited
FY 2021 filings availableHemmo Pharmaceuticals Private Limited reported revenue of ₹133.32 Cr (up 45% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 45% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹133.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 46.2% | ||||
| Net Profit Margin | 32% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hemmo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hemmo Pharmaceuticals Private Limited
Hemmo Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surinder Bhawanidas Gulati Also directs: Piramal Pharma II Private Limited | Director | 22 Jun 2021 | 5 Years 4 Months | As last reported |
| Madhu Vikram Utamsingh Also directs: Hemmo Pharma LLP, Shyro Health Private Limited | Director | 01 Aug 2008 | 18 Years 3 Months | As last reported |
| Amit Anant Bapat Also directs: Piramal Pharma II Private Limited | Director | 26 Nov 2021 | 4 Years 11 Months | As last reported |
Peer comparison
Hemmo Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alpa Laboratories Limited | ₹135.8 Cr (FY 2025) | 10.0% | Indore, Madhya Pradesh, India | |||
| Ravoo's Laboratories Limited | ₹134.97 Cr (FY 2024) | 4.0% | Hyderabad, Telangana, India | |||
| Surabhi Industries (India) Private Limited | ₹133.75 Cr (FY 2024) | -37.0% | Hyderabad, Telangana, India | |||
| Vikram Thermo (India) Limited | ₹133.72 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Strassenburg Pharmaceuticals Private Ltd. | ₹133.69 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Hemmo Pharmaceuticals Private Limitedthis company | ₹133.32 Cr (FY 2021) | ₹42.7 Cr | 32% | 45.0% | 325 | Mumbai, Maharashtra, India |
| Makers Laboratories Ltd | ₹132.64 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India | |||
| Saimirra Innopharm Private Limited | ₹132.6 Cr (FY 2025) | 65.0% | Chennai, Tamil Nadu, India | |||
| Bengal Chemicals and Pharmaceuticals Ltd | ₹132.57 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Hemmo Pharmaceuticals Private Limited, buy the company report.
Auditor
Hemmo Pharmaceuticals Private Limited is audited by C. N. K. & Associates LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. N. K. & Associates LLP | FY 2021 | 101961W/W100036 |
Shareholding
The shareholding of Hemmo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hemmo Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2022 | 100561084 | Axis Bank Limited | ₹25 Cr | Open | |
| 22 Sep 1998 | 90218208 | Indian Overseas Bank | ₹3.2 Lakh | Satisfied | |
| 18 Sep 1995 | 90217939 | Oriental Bank of Commerce | ₹50 Lakh | Satisfied | |
| 03 Oct 1992 | 90216183 | Oriental Bank of Commerce | ₹20 Lakh | Satisfied | |
| 19 May 1992 | 90217579 | Oriental Bank of Commerce | ₹15 Lakh | Satisfied |
To see the full charge records of Hemmo Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Hemmo Pharmaceuticals Private Limited has 1 deal on record (1 acquisition); the latest was in March 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Acquisition | ₹775 Cr | Buyer: Piramal Pharma Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hemmo Pharmaceuticals Private Limited has 19 court cases on record: 13 filed by Hemmo Pharmaceuticals, 6 filed against it. 1 case is pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 3 | 1 |
| NCLT | 4 | 0 | 0 |
| District courts | 2 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed against the company by Accent Metals Pvt. Ltd. and 3 Ors. and 2 others | Disposed |
| Bombay High Court | Court case (SJ) | Filed by the company against Dawood Shoes Pvt Ltd and Anr | Disposed |
| Bombay High Court | Company petition | Filed by the company against Dawood Shoes P.Ltd. | Disposed |
| Bombay High Court | Writ petition | Filed by the company against The State of Maharashtra and Ors | Pending |
| NCLT, Mumbai | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Hemmo Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hemmo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hemmo Pharmaceuticals Private Limited has a workforce of 325 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Hemmo Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Hemmo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hemmo Pharmaceuticals Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Amit Anant Bapat ceased to be Additional Director on 29 Nov 2021.
22 earlier events are in the company report.
Frequently asked questions
Hemmo Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Hemmo Pharmaceuticals was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 07 November 1979 and is registered under CIN U17100MH1979PTC021857. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Hemmo Pharmaceuticals was incorporated on 07 November 1979. It is registered with the Registrar of Companies, Mumbai.
Hemmo Pharmaceuticals had 3 directors:
- Surinder Bhawanidas Gulati - Director
- Madhu Vikram Utamsingh - Director
- Amit Anant Bapat - Director
The CIN (Corporate Identification Number) of Hemmo Pharmaceuticals is U17100MH1979PTC021857. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Hemmo Pharmaceuticals is at 114 Turf Estate 365 Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011.
Hemmo Pharmaceuticals can be reached through the website hemmopharma.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Hemmo Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
No. Hemmo Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Hemmo Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Hemmo Pharmaceuticals has 1 deal on record (1 acquisition); the latest was in March 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
